Myriad Genetics and Pharma Mar Enter Into Companion Diagnostic Agreement

News   Aug 06, 2012

 
Myriad Genetics and Pharma Mar Enter Into Companion Diagnostic Agreement
 
 
 

RELATED ARTICLES

Adaptive PCR Technique Offers Simpler Alternative

News

Researchers claim their new technique can use L-DNA to sidestep many of the issues that make current PCR techniques frustrating.

READ MORE

Barrier to Liquid Biopsies Overcome with Blood Stabilization Technique

News

A new technique that prolongs the lifespan of blood samples could be a breakthrough for liquid biopsy assays.

READ MORE

Could New Treatment Strategy Overcome Drug Resistance in Testicular Cancer?

News

In a new study, scientists show that a targeted drug blocking the action of a cancer-driving protein can kill testicular cancer cells and, alongside chemotherapy, could reverse drug resistance.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE